Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers

Bhoj R Singh Division of Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, IndiaIn a recently published article1 moxalactam has been claimed to be very effective on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae, concluding “MOX demons...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	Singh BR
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2018-03-01
Schriftenreihe:	Infection and Drug Resistance
Schlagworte:	Moxalactam Latamox Carbapenem MBL ESBL
Online-Zugang:	https://www.dovepress.com/moxalactam-is-not-more-active-on-extended-spectrum-beta-lactamase-esbl-peer-reviewed-article-IDR
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!